60 employees
HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.
2008
$40M
from 2 investors over 2 rounds
Hemoshear raised $40M on February 10, 2021
Investors: Adage Capital Management and Suvretta Capital Management LLC